Patent · US Active

Inhibitor Peptides of ERK-type MAP kinase

US10494410B2 · kind B2 · utility

0Cited by

2References

7Claims

0Family size

Assignees

Université Pierre et Marie Curie · FR
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE · FR

Inventors

Jocelyne Caboche · Vicq, FR
Peter Vanhoutte · Varsenare, BE

Key dates

Filing date	Feb 22, 2016
Grant date	Dec 3, 2019
Priority date	—
Expiry date	Jun 14, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/70
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention concerns peptides useful as MAP kinase/ERK pathway-specific inhibitors relative to a given substrate in a given subcellular compartment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.